Impact at the heart of research design

Team STAMINA designs, develops and leads multi-centre clinical trials that evaluate the impacts of lifestyle and other and complex behavioural interventions in cancer populations.

Our studies are implicitly designed to improve cancer-specific outcomes for patients. We generate research that is applicable to both real-world patients and real-world clinical practice. As a result, our projects have shaped guidelines and care practices that have led to meaningful change for thousands of cancer patients and survivors.

Read more about our research projects or download our full 2021 REF impact case study below.

REF 2021 Impact Case Study (PDF)

Our impact at a glance

  • Defining best practice

    New standards of best practice have been established citing our research. These have been endorsed by:

    • the European Association of Urology (EAU)

    • the European Association of Radiotherapy and Oncology (ESTRO)

    • the European Society of Urogenital Radiology (ESUR)

    • the International Society of Geriatric Oncology (SIOG)

  • Changing thousands of lives

    Our research has shaped practice internationally, changing clinical approaches. For thousands of patients this has meant:

    • improved cancer-specific quality of life

    • improved cancer-related fatigue

    • combatting the adverse effects of primary cancer treatments

    • improved cancer progression outcomes

  • New services and training

    Or national level projects have directly led to the establishment of a new services, including:

    • exercise and rehabilitation services for cancer survivors

    • specialist cancer care and exercise training programmes for exercise and health care professionals

Patients and exercise professionals share the impact of the Cancer Activity Programme (CAP).

Video credit: Nuffield Health

What patients and professionals say

“We have learnt increasingly how important exercise is to outcomes following treatment for breast cancer. I now routinely recommend exercise to patients as one of the things they can do … to reduce the risk of recurrence”

— Rebecca Roylance, Consultant Medical Oncologist, University College London Hospitals

“As a direct result of the cancer research led by SHU (such the STAMINA trial and the Active Everyday project) our clinical practice has improved — we have been able to provide substantive and evidence-based referrals for people living with and beyond cancer.”

— Professor Diana Greenfield, Clinical Academic Lead, Nursing and Consultant Nurse in Specialised Cancer Services, Sheffield Teaching Hospitals NHS Trust

“It’s made a complete difference to my life in general, my head you know, everything. I look forward to everything.”

— Advanced prostate cancer patient

Read more in our REF 2021 Impact Case Study (PDF).